Company / Current Liabilities per Share
Cogent Biosciences, Inc. Current Liabilities per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.50
FY2025
5-year range
$0.44 / $0.54
FY2021-FY2025
Trend
-7.5%
vs FY2024
Sector context
#155 of 210
Health Care
What the data says
At $0.50, Cogent Biosciences, Inc.'s current liabilities per share ranks #56 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 9 years, ranging from $0.44 in FY2021 to $1.74 in FY2019.
Based on SEC 10-K filings.
0.50 in FY2025 with a 5-year CAGR of -15.9%.
Increased from $0.48 to $0.50 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +2.8%
- 5-Year CAGR
- -15.9%
- 10-Year CAGR
- -
Sector benchmark
#56 of 210 in Health CareTop 26% of 210This company $0.50 Sector average $23.75
▼
-97.9% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 7.5% year-over-year.
- Ranks #155 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2019.
- Lowest current liabilities per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.50 | -7.5% |
| FY2024 | $0.54 | +12.0% |
| FY2023 | $0.48 | +4.8% |
| FY2022 | $0.46 | +3.7% |
| FY2021 | $0.44 | -62.7% |
| FY2020 | $1.18 | -32.0% |
| FY2019 | $1.74 | +73.5% |
| FY2018 | $1.00 | -8.7% |
| FY2017 | $1.10 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026